February
                                                                    1
                                                                    2023
                                                                
                                                                
                                                                February 1, 2023. – Toronto, ON: LifeLabs is pleased to share the launch of SignateraTM, a highly sensitive, personalized molecular residual disease assay (MRD) test developed by Natera for treatmen...                                                            
                                                            
                                                        
                                                                    October
                                                                    10
                                                                    2019
                                                                
                                                                
                                                                FOR RELEASE—Toronto, Ontario (October 10, 2019) – LifeLabs, Canada’s leading diagnostic and laboratory testing company, is proud to announce it will offer its pharmacogenomics test TreatGxplus a...                                                            
                                                            
                                                         
                        